A detailed history of Mather Group, Llc. transactions in Abbott Laboratories stock. As of the latest transaction made, Mather Group, Llc. holds 33,137 shares of ABT stock, worth $3.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
33,137
Previous 56,649 41.5%
Holding current value
$3.8 Million
Previous $5.89 Million 35.83%
% of portfolio
0.05%
Previous 0.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$100.07 - $118.13 $2.35 Million - $2.78 Million
-23,512 Reduced 41.5%
33,137 $3.78 Million
Q2 2024

Jul 08, 2024

BUY
$100.73 - $112.44 $3.31 Million - $3.7 Million
32,868 Added 138.21%
56,649 $5.89 Million
Q1 2024

Apr 08, 2024

SELL
$109.52 - $120.96 $1.33 Million - $1.47 Million
-12,150 Reduced 33.81%
23,781 $2.7 Million
Q4 2023

Feb 05, 2024

BUY
$90.19 - $110.4 $71,159 - $87,105
789 Added 2.25%
35,931 $3.95 Million
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $210,357 - $252,393
2,202 Added 6.68%
35,142 $3.4 Million
Q2 2023

Aug 08, 2023

BUY
$100.78 - $112.29 $187,753 - $209,196
1,863 Added 5.99%
32,940 $3.59 Million
Q1 2023

May 09, 2023

BUY
$96.86 - $114.01 $59,375 - $69,888
613 Added 2.01%
31,077 $3.15 Million
Q4 2022

Mar 10, 2023

BUY
$95.06 - $111.52 $365,220 - $428,459
3,842 Added 14.43%
30,464 $3.35 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $58,056 - $67,218
600 Added 2.31%
26,622 $2.58 Million
Q2 2022

Aug 16, 2022

BUY
$102.07 - $123.37 $242,110 - $292,633
2,372 Added 10.03%
26,022 $2.83 Million
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $2.7 Million - $3.29 Million
23,650 New
23,650 $2.8 Million
Q4 2020

Feb 12, 2021

SELL
$105.0 - $114.42 $1.39 Million - $1.52 Million
-13,256 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$91.64 - $111.29 $122,156 - $148,349
1,333 Added 11.18%
13,256 $1.44 Million
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $912,944 - $1.17 Million
11,923 New
11,923 $1.09 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Mather Group, Llc. Portfolio

Follow Mather Group, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.